Cision Mediastudio View Media Precigen is a biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult to treat diseases with high unmet patient need. Precigen, inc. (formerly intrexon corporation, nasdaq: pgen) is an american biotechnology company. its president and ceo is helen sabzevari.
Home Precigen Precigen (nasdaq: pgen) is a biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult to treat diseases with high unmet patient need . Company profile for precigen, inc. (pgen) stock, with a description, list of executives, contact details and other key facts. Precigen is a public company based in germantown (united states), founded in 1998 by thomas david reed. it operates as a gene and cell therapy biopharmaceutical company focused on immuno oncology, autoimmune, and infectious diseases. precigen has raised $234m in funding. Precigen inc (precigen) is a clinical stage biopharmaceutical company that carries out the discovery and development of gene and cell therapies. the company's activities focus on advancing precision technology in the areas of immuno oncology, autoimmune disorders, and infectious diseases.
Home Precigen Precigen is a public company based in germantown (united states), founded in 1998 by thomas david reed. it operates as a gene and cell therapy biopharmaceutical company focused on immuno oncology, autoimmune, and infectious diseases. precigen has raised $234m in funding. Precigen inc (precigen) is a clinical stage biopharmaceutical company that carries out the discovery and development of gene and cell therapies. the company's activities focus on advancing precision technology in the areas of immuno oncology, autoimmune disorders, and infectious diseases. Precigen, inc. is a dedicated discovery and clinical stage biopharmaceutical company advancing gene and cell therapies. the company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno oncology, autoimmune disorders and infectious diseases. Precigen (nasdaq: pgen) is a commercial stage biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult to treat diseases with high unmet. Precigen, inc. operates as a biopharmaceutical company. the company develops gene and cell therapies to target the diseases in immuno oncology, autoimmune disorders, and infections. Precigen, inc.,a discovery and clinical stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno oncology, autoimmune.
Contact Precigen Precigen, inc. is a dedicated discovery and clinical stage biopharmaceutical company advancing gene and cell therapies. the company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno oncology, autoimmune disorders and infectious diseases. Precigen (nasdaq: pgen) is a commercial stage biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult to treat diseases with high unmet. Precigen, inc. operates as a biopharmaceutical company. the company develops gene and cell therapies to target the diseases in immuno oncology, autoimmune disorders, and infections. Precigen, inc.,a discovery and clinical stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno oncology, autoimmune.
Comments are closed.